Anavex Life Sciences Financial results

Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs

Anavex Life Sciences Reports Fiscal 2017 Financial Results And Provides Update On Therapeutic Programs Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK – December 11, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases…

Money 1 1120 x 480

Anavex Reports Fiscal Third Quarter 2017 Financial Results

NEW YORK – August 7, 2017 – Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer’s disease, other central nervous system (CNS) diseases, pain and various types of cancer, today reported financial results for the fiscal quarter…